Feedback

Nanotechnology in Thoracic Surgery

David A. Mahvi, MD, Mark W. Grinstaff, PhD, Yolonda L. Colson, MD, PhD
Nanotechnology in Thoracic Surgery is a topic covered in the Pearson's General Thoracic.

To view the entire topic, please or .

STS Cardiothoracic Surgery E-Book from The Society of Thoracic Surgeons provides expert guidance for Cardiac and Thoracic Surgery. Sections include Pearson’s General Thoracic, Esphageal, Adult Cardiac, and Pediatric and Congenital Cardiac Surgery. Explore these free sample topics:

-- The first section of this topic is shown below --

Key Elements

  • An array of nanotherapeutic delivery platforms are currently being investigated to provide novel therapeutic options for thoracic malignancies
  • Multiple chemotherapeutic drugs and/or gene delivery via nanotechnology platforms demonstrate efficacy in pre-clinical and limited clinical studies
  • New polymer formulations that improve biocompatibility and tumor targeting with stimuli-responsiveness are maximizing therapeutic efficacy and minimizing adverse effects
  • Nanotheranostics is a new field combining diagnostic and therapeutic modalities that will expedite next-generation, personalized medicine

-- To view the remaining sections of this topic, please or --

Key Elements

  • An array of nanotherapeutic delivery platforms are currently being investigated to provide novel therapeutic options for thoracic malignancies
  • Multiple chemotherapeutic drugs and/or gene delivery via nanotechnology platforms demonstrate efficacy in pre-clinical and limited clinical studies
  • New polymer formulations that improve biocompatibility and tumor targeting with stimuli-responsiveness are maximizing therapeutic efficacy and minimizing adverse effects
  • Nanotheranostics is a new field combining diagnostic and therapeutic modalities that will expedite next-generation, personalized medicine

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: May 27, 2020